| Target Price | NZ$47.43 |
| Price | NZ$45.00 |
| Potential |
5.40%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Fisher & Paykel Healthcare 2027 .
The average Fisher & Paykel Healthcare target price is NZ$47.43.
This is
5.40%
register free of charge
NZ$53.55
19.00%
register free of charge
NZ$39.39
12.47%
register free of charge
|
|
| A rating was issued by 15 analysts: 8 Analysts recommend Fisher & Paykel Healthcare to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fisher & Paykel Healthcare stock has an average upside potential 2027 of
5.40%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion NZ$ | 2.31 | 2.59 |
| 14.22% | 12.16% | |
| Net Margin | 20.30% | 21.74% |
| 8.74% | 7.12% |
15 Analysts have issued a sales forecast Fisher & Paykel Healthcare 2027 . The average Fisher & Paykel Healthcare sales estimate is
This results in the following potential growth metrics:
15 Fisher & Paykel Healthcare Analysts have issued a net profit forecast 2027. The average Fisher & Paykel Healthcare net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share NZ$ | 0.79 | 0.96 |
| 23.44% | 21.52% | |
| P/E | 46.93 | |
| EV/Sales | 10.13 |
15 Analysts have issued a Fisher & Paykel Healthcare forecast for earnings per share. The average Fisher & Paykel Healthcare EPS is
This results in the following potential growth metrics and future valuations:
Fisher & Paykel Healthcare...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


